Stay updated on BI 836858 & Decitabine Combo in AML Clinical Trial
Sign up to get notified when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.

Latest updates to the BI 836858 & Decitabine Combo in AML Clinical Trial page
- Check4 days agoChange DetectedLocations section structure updated: added a general Locations section and state entries for Florida, Illinois, New York, and Ohio; removed Florida Locations, Illinois Locations, New York Locations, and Ohio Locations. Revision updated from v3.3.2 to v3.3.3.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 with no change to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedFunding-status notice banner removed from the page, eliminating information about potential delays and limited site responses.SummaryDifference0.3%

- Check54 days agoChange DetectedThe page shows minor layout and formatting updates to the study record without altering core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedAdditions introduce an operational status notice and new version v3.2.0; deletions remove the prior v3.1.0 tag. The most significant change is the updated operational status messaging and the version bump.SummaryDifference4%

- Check90 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to BI 836858 & Decitabine Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.